United States · Bill · HR
H.R. 1732 (115th)
Synthetic Drug Control Act of 2017
Introduced
27 March 2017
Last action
—
Status
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Sponsors
—
Subjects
Discovery layer
Source updated
11 August 2025
Summary
Synthetic Drug Control Act of 2017 This bill directs the Drug Enforcement Administration to update schedule I of the Controlled Substances Act to include certain synthetic substances. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. The bill exempts from treatment as a controlled substance any such synthetic substance that is manufactured, distributed, and used exclusively for research.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 27 March 2017
Introduced in House (PDF)
Introduced in House · EN · 27 March 2017
Introduced in House
summary · EN · 27 March 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/house-bill/1732
- Open data entity: https://api.congress.gov/v3/bill/115/hr/1732